✦ LIBER ✦

Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines

✍ Scribed by Peter K. Kaiser, Alan F. Cruess, Peter Bogaert, Kamlesh Khunti, Simon P. Kelly

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

“Balancing risk in ophthalmic prescribin

✍ Bernd Kirchhof 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 56 KB

Erratum to: Balancing risk in ophthalmic

✍ Peter K. Kaiser, Alan F. Cruess… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 74 KB

Identification of risks associated with

✍ Lisa Hammond, Elaine Marsden, Niamh O’Hanlon, Fionnuala King, Martin Charles Hen 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 306 KB

Safety of using anti-TNF-α blockers in c

✍ Kounis, Nicholas G.; Soufras, George D.; Kounis, George N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Assessment of the Organ-dose Reduction a

✍ Fuji, H.; Schneider, U.; Ishida, Y.; Konno, M.; Murayama, S.; Yamashita, H.; Kas 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The safety of using anti-VEGF: Is there

✍ David Wong; Antonia M. Joussen 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 68 KB